NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI): Entry into a Material Definitive Agreement
NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 3 neonctechnologies_ex10-1.htm EXHIBIT 10.1 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT THIS SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of June 10, 2026, is entered into by and between NeOnc Technologies Holdings, Inc., a Delaware corporation (the “Company”
How this was made
The 30-second read
Why it matters
The company plans to issue and sell up to $5,000,000 of Series A convertible preferred stock to investors under a Regulation D/unregistered sales exemption, creating potential dilution and convertible overhang.
Market read
Convertible preferred financings often move the stock via dilution expectations and conversion mechanics; this 8-K is the primary disclosure of the deal size cap and structure.
What to watch
Traders should verify the full exhibit for conversion price/discount, voting rights, redemption provisions, and investor concentration; those details can materially change dilution and near-term selling pressure.
Background
The filing is an SEC 8-K (Item 1.01 and 3.02) attaching a securities purchase agreement for a new series of convertible preferred stock (Series A Convertible Preferred Stock).
Ticker impact
NeOnc Technologies Holdings entered a securities purchase agreement to sell up to $5,000,000 of Series A convertible preferred stock.
Near-term: potential downside/volatility from dilution/convertible overhang; medium-term depends on whether proceeds fund catalysts and conversion terms.
This is a primary SEC filing announcing the terms and size cap of a convertible preferred issuance; however, the excerpt does not include conversion mechanics, investor identity, or use of proceeds, limiting precision on dilution magnitude and timing.
Market effects
Adds another example of biotech/healthcare microcap capital raising via convertible preferred, reinforcing ongoing risk appetite constraints for pre-profit issuers.
Primarily impacts US small-cap/biotech trading flows; limited spillover beyond the issuer’s peer group.
Low—this is company-specific capital structure news with no stated cross-border operational impact.
Counterpoint
If the convertible terms are favorable (e.g., capped conversion price, limited beneficial ownership, or short conversion window), the overhang may be smaller than typical financing risk.
Key entities
- issuerNeOnc Technologies Holdings, Inc.
Company entering the securities purchase agreement for Series A convertible preferred stock financing.
- securitySeries A Convertible Preferred Stock
New series authorized by the company; includes conversion shares issuable upon conversion.
